CDC MPT FUNDS
NSAR-B, EX-27, 2000-12-28
Previous: CDC MPT FUNDS, NSAR-B, EX-27, 2000-12-28
Next: CDC MPT FUNDS, NSAR-B, EX-99, 2000-12-28



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0001072029
<NAME> CDC MPT+ FUNDS
<SERIES>
   <NUMBER> 013
   <NAME> CDC MPT+ GLOBAL INDEPENDENCE FUND INSTITUTIONAL SHAREES

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-START>                             NOV-01-1999
<PERIOD-END>                               OCT-31-2000
<INVESTMENTS-AT-COST>                         31978474
<INVESTMENTS-AT-VALUE>                        31978474
<RECEIVABLES>                                   437288
<ASSETS-OTHER>                                 1680978
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                34096740
<PAYABLE-FOR-SECURITIES>                             0
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                       173822
<TOTAL-LIABILITIES>                             173822
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                      30386111
<SHARES-COMMON-STOCK>                          3020459
<SHARES-COMMON-PRIOR>                          2567577
<ACCUMULATED-NII-CURRENT>                      1031585
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                        2365247
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                        139975
<NET-ASSETS>                                  33922918
<DIVIDEND-INCOME>                                    0
<INTEREST-INCOME>                              1954286
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                (752648)
<NET-INVESTMENT-INCOME>                        1201638
<REALIZED-GAINS-CURRENT>                       2453459
<APPREC-INCREASE-CURRENT>                      (19150)
<NET-CHANGE-FROM-OPS>                          3635948
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                     (437301)
<DISTRIBUTIONS-OF-GAINS>                      (770089)
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                        4016307
<NUMBER-OF-SHARES-REDEEMED>                   (188026)
<SHARES-REINVESTED>                             873447
<NET-CHANGE-IN-ASSETS>                         7130284
<ACCUMULATED-NII-PRIOR>                         267249
<ACCUMULATED-GAINS-PRIOR>                       681877
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                           638316
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                1035988
<AVERAGE-NET-ASSETS>                          32667122
<PER-SHARE-NAV-BEGIN>                            10.43
<PER-SHARE-NII>                                   0.39
<PER-SHARE-GAIN-APPREC>                           0.82
<PER-SHARE-DIVIDEND>                            (0.15)
<PER-SHARE-DISTRIBUTIONS>                       (0.26)
<RETURNS-OF-CAPITAL>                              0.00
<PER-SHARE-NAV-END>                              11.23
<EXPENSE-RATIO>                                   2.30


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission